Vanguard Group
BIOA

Vanguard Group’s BioAmber Inc. BIOA Stock Holding History

Vanguard Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-161,049
Closed -$79K – 4089
2017
Q3 		$79K Sell
161,049
-142,311
-47% -$170K ﹤0.01% 4004
2017
Q2 		$780K Buy
303,360
+27,278
+10% +$62.7K ﹤0.01% 3630
2017
Q1 		$641K Buy
276,082
+127,493
+86% +$485K ﹤0.01% 3700
2016
Q4 		$818K Buy
148,589
+42,560
+40% +$204K ﹤0.01% 3621
2016
Q3 		$450K Hold
106,029
– – ﹤0.01% 3779
2016
Q2 		$316K Hold
106,029
– – ﹤0.01% 3875
2016
Q1 		$445K Buy
106,029
+19,732
+23% +$82.8K ﹤0.01% 3814
2015
Q4 		$534K Buy
86,297
+5,772
+7% +$43.5K ﹤0.01% 3814
2015
Q3 		$430K Buy
80,525
+19,266
+31% +$127K ﹤0.01% 3895
2015
Q2 		$527K Buy
61,259
+13,513
+28% +$124K ﹤0.01% 3848
2015
Q1 		$416K Buy
47,746
+14,130
+42% +$124K ﹤0.01% 3876
2014
Q4 		$282K Buy
33,616
+2,900
+9% +$26.4K ﹤0.01% 3846
2014
Q3 		$307K Buy
+30,716
New +$359K ﹤0.01% 3827

Other funds holding BIOA

NIPH
NN Investment Partners Holdings The Hague, Netherlands $18.6B AUM 18.31% 1-Year Est. Return
RS
Robeco Schweiz Zurich, Switzerland $6.23B AUM 86.54% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
RJFSA
Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Vanguard Group's BIOA Position: Q4 2017 in Review

Vanguard Group sold out of BioAmber Inc. (BIOA) in Q4 2017, closing a stake of 161,049 shares — an estimated $79K sold.

Vanguard Group first reported a position in BIOA in Q3 2014 and held it in 13 quarters. The position peaked at $818K in Q4 2016. 26 funds tracked by Wall St. Rank hold BIOA as of Q4 2017.

  • Vanguard Group reported no remaining BioAmber Inc. position as of Q4 2017 after selling out during the quarter.
  • Vanguard Group sold 161,049 BioAmber Inc. shares in Q4 2017, an estimated $79K.
  • Vanguard Group first reported a position in BioAmber Inc. in Q3 2014 and held it in 13 quarters.
  • Vanguard Group's BioAmber Inc. position peaked at $818K in Q4 2016.
  • 26 funds tracked by Wall St. Rank held BioAmber Inc. as of Q4 2017.

Based on Vanguard Group's 13F filing for Q4 2017, filed 14 Feb 2018.